Who owns the BSIM THERAPEUTICS trademark?

The BSIM THERAPEUTICS trademark is owned by BSIM Therapeutics.

What class is the BSIM THERAPEUTICS trademark registered in?

The BSIM THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for BSIM THERAPEUTICS?

The USPTO serial number for BSIM THERAPEUTICS is 79283857.

What is the registration number for BSIM THERAPEUTICS?

BSIM THERAPEUTICS is registered under USPTO registration number 6398721.

Sealvo

Home Search: BSIM THERAPEUTICSBSIM THERAPEUTICS #79283857

Back

Updated Oct 11, 2026·36 searches this week

View on USPTO TSDR Find similar marks

BSI

USPTO Trademark Record

REGISTERED

BSIM THERAPEUTICS

SN 79283857·Reg 6398721·Filed Mar 11, 2020

Owner BSIM Therapeutics

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

BSIM THERAPEUTICS (Serial No. 79283857), Registration No. 6398721, is a registered US trademark filed on Mar 11, 2020 by BSIM Therapeutics. This trademark covers Class 042 (Scientific, technology & SaaS services).

Renewal window: June 29, 2027261 days remaining

Mark Intelligence

BSIM THERAPEUTICS (Reg. #6398721) is a registered US trademark that has been protecting its owner, BSIM Therapeutics, since 2020. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 3 opposition proceedings during prosecution.

FILED

Mar 11, 2020

SERIAL

79283857

REG#

6398721

REGISTERED

Jun 29, 2021

Filing Information

StatusREGISTERED

Filing DateMar 11, 2020

Serial Number79283857

Registration No.6398721

Registration DateJun 29, 2021

Status DateJun 29, 2021

Published for OppositionApr 13, 2021

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

36 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jun 29, 2026

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 08, 2021

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Oct 20, 2021

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 20, 2021

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Sep 29, 2021

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jun 29, 2021

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Apr 13, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 13, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Apr 12, 2021

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 24, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Mar 24, 2021

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Mar 24, 2021

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 05, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

EXAMINERS AMENDMENT -WRITTEN

Feb 25, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Feb 25, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 25, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Feb 25, 2021

EXAMINER'S AMENDMENT ENTERED

ASSIGNED TO LIE

Jan 29, 2021

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 29, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 29, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Oct 21, 2020

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Oct 21, 2020

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Oct 21, 2020

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

Oct 21, 2020

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Oct 21, 2020

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Oct 21, 2020

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 21, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

REFUSAL PROCESSED BY IB

Jul 24, 2020

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 06, 2020

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 06, 2020

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jun 09, 2020

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jun 08, 2020

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jun 02, 2020

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Apr 28, 2020

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 24, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Apr 23, 2020

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

DEL

DELPHIAN THERAPEUTICS

98830481

Schedule 1 Therapeutics, Inc.

REGISTERED

CON

CONSYNANCE THERAPEUTICS

86749993

ConSynance Therapeutics, Inc.

REGISTERED

KEE

KEENOVA THERAPEUTICS

79445783

Mallinckrodt Pharmaceuticals Ireland Limited

REGISTERED

XIL

XILIO THERAPEUTICS

88981516

XILIO DEVELOPMENT, INC.

REGISTERED

Other Marks by Douglas R. Wolf

Additional USPTO filings handled by the same attorney of record.

ART

ART SERIES

79000721

REGISTERED

MYR

MYROADHELP

98627529

REGISTERED

LOG

LogoMark

98627538

REGISTERED

JUV

JUVIA

99245056

REGISTERED

BSIM THERAPEUTICS

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Douglas R. Wolf

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company